This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
The Enterprise DG of the European Commission retained Charles River Associates to undertake a study investigating whether there is a worldwide crisis in innovation in the pharmaceutical sector, the reasons behind this crisis, and the tools available to kick-start innovation.
CRA’s Life Sciences Litigation team provides periodic summaries of notable developments in litigation. In this Insights, we note an antitrust case addressing...
Potentially curative cell and gene therapies represent a key shift in patient care and will have considerable impact across the patient journey, affecting the...
Tim Wilsdon is a panelist during the session titled “Access to Oncology Combinations – the ‘Combination Challenge.'” Michele Pistollato is presenting two...
CRA is proud to support the New England region of the LLS Man & Woman of the year campaign, a philanthropic competition to support blood cancer research. Ned...
